Home/Filings/4/0001378550-26-000003
4//SEC Filing

Lowenthal Richard E 4

Accession 0001378550-26-000003

CIK 0001671858other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 4:19 PM ET

Size

7.6 KB

Accession

0001378550-26-000003

Insider Transaction Report

Form 4
Period: 2026-01-02
Lowenthal Richard E
DirectorPRESIDENT AND CEO10% Owner
Transactions
  • Award

    Stock option (right to buy)

    2026-01-02+875,000875,000 total
    Exercise: $11.49Exp: 2036-01-01Common Stock (875,000 underlying)
  • Award

    Stock Option (right to buy)

    2026-01-02+240,000240,000 total(indirect: By Spouse)
    Exercise: $11.49Exp: 2036-01-01Common Stock (240,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option shall vest in a series of 48 equal monthly installments measured from January 1, 2026.

Issuer

ARS Pharmaceuticals, Inc.

CIK 0001671858

Entity typeother

Related Parties

1
  • filerCIK 0001378550

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:19 PM ET
Size
7.6 KB